BRCA1 and cancer: To successfully convey intricate genetic and cancer risk information related to BRCA1/2 mutation, it is imperative that we gain a deeper understanding of the distinct requirements of this group and locate helpful tools to assist them in navigating the intricate clinical realm concerning risk reduction and symptom management.